Sign in
8-K/A

Current Report

Ovid Therapeutics Inc. Filed Acc 0001564590-19-022662

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading ovid-8ka_20190617.htm…